Cost benefit of influenza vaccination in healthy, working adults: an economic analysis based on the results of a clinical trial of trivalent live attenuated influenza virus vaccine

By Nichol K.L.   Mallon K.P.   Mendelman P.M.  

Vaccine, Vol. 21, Iss. 17, 2003-05 ,pp. : 2216-2226

Elsevier

Access to resources Recommend Favorite

Safety and immunogenicity of a live-attenuated influenza vaccine blended and filled at two manufacturing facilities

By Nolan T.   Lee M.-S.   Cordova J.M.   Cho I.   Walker R.E.   August M.J.   Larson S.   Coelingh K.L.   Mendelman P.M.  

Vaccine, Vol. 21, Iss. 11, 2003-03 ,pp. : 1224-1231

Elsevier

Access to resources Recommend Favorite

Mucosal immune response to trivalent live attenuated intranasal influenza vaccine in children

By Boyce T.G.   Gruber W.C.   Coleman-Dockery S.D.   Sannella E.C.   Reed G.W.   Wolff M.   Wright P.F.  

Vaccine, Vol. 18, Iss. 1, 1999-08 ,pp. : 82-88

Elsevier

Access to resources Recommend Favorite

Cold-adapted live influenza vaccine versus inactivated vaccine: systemic vaccine reactions, local and systemic antibody response, and vaccine efficacy - A meta-analysis

By Beyer W.E.P.   Palache A.M.   de Jong J.C.   Osterhaus A.D.M.E.  

Vaccine, Vol. 20, Iss. 9, 2002-01 ,pp. : 1340-1353

Elsevier

Access to resources Recommend Favorite

Prevention of influenza by the intranasal administration of cold-recombinant, live-attenuated influenza virus vaccine: importance of interferon- production and local IgA response

By Tomoda T.   Morita H.   Kurashige T.   Maassab H.F.  

Vaccine, Vol. 13, Iss. 2, 1995-02 ,pp. : 185-190

Elsevier

Access to resources Recommend Favorite